Combined pars plana vitrectomy with phacoemulsification for rhegmatogenous retinal detachment repair

Figures & data

Table 1 Patients’ characteristics

Characteristics	n=1017	Percentage (%)
Sex
Female	355	34.9
Male	662	65.1
Side
Left	552	54.3
Right	465	45.7
Macula status
On	430	42.3
Off	587	57.7
Lens status
Phakic	501	49.3
Pseudophakic	516	50.7
Phacoemulsification	501	49.3
Primary PVR	93	9.1
Tamponade
Gas	879	86.4
Silicone oil	138	13.6

Abbreviation: PVR, proliferative vitreoretinopathy.

Table 2 Associations between the occurrence of re-detachment and phacoemulsification, high-risk factors and patients’ characteristics

Predictor	Re-detachment			Chi-squared test
	No (n)	Yes (n)	Yes (%)	X^2	p-value
Phaco
No	461	55	10.7	0.22	0.641
Yes	453	48	9.6
PVR
No	841	83	9.0	13.21	0.0003
Yes	73	20	21.5
Tamponade
Gas	803	76	8.6	14.45	0.0001
Silicone oil	111	27	19.6
Retinopexy
Cryo	435	57	11.6	2.35	0.309
Endolaser	201	18	8.2
Combined	278	28	9.2
Macula status
On	397	33	7.7	4.47	0.034
Off	517	70	11.9

Abbreviation: PVR, proliferative vitreoretinopathy.

Table 3 Association between the occurrence of re-detachment and phacoemulsification for high-risk groups

	Re-detachment			Chi-squared test
	No (n)	Yes (n)	Yes (%)	X^2	p-value
Primary PVR (n=93) Phaco
No	47	10	17.5	0.83	0.362
Yes	26	10	27.8
Primary silicone oil (n=138) Phaco
No	66	14	17.5	0.25	0.617
Yes	45	13	22.4

Abbreviation: PVR, proliferative vitreoretinopathy.